Page 57 - CPG endometrial cancer

แนวทางการรกั ษาดว้ ยยาในผปู้ ว่ ยโรคมะเร็งเต้านมทมี่ คี วามผิดปกตทิ างพนั ธกุ รรม BRCA

of cisplatin chemotherapy in patients with
BRCA1-positive metastatic breast cancer. Breast
Cancer Res. 14, R110 (2012).
17. Isakoff SJ, Mayer EL, He L, Traina TA,
Carey LA & Krag KJ, et al. TBCRC009: a
multicenter phase ii clinical trial of platinum
monotherapy with biomarker assessment in
metastatic triple-negative breast cancer. J. Clin.
Oncol. 33, 1902–1909 (2015)
18. Robson M, Im SA, Senkus E, Xu
B, Domchek SM, Masud N, et al. Olaparib for
Metastatic Breast Cancer in Patients with a
Germline BRCA Mutation. N Engl J Med 2017;
377:523-533.
19. Litton JK, Rugo HS, Ettl J, Sara A Hurvitz SA,
Gon?alves A, et al. Talazoparib in Patients with
Advanced Breast Cancer and a Germline BRCA
Mutation. N Engl J Med 2018 Aug 23;379(8):753-
763.

4498